Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non–small cell lung cancer
Rie Furukawa, Hiroyuki Inoue, Yasuto Yoneshima, Hirono Tsutsumi, Eiji Iwama, Yuki Ikematsu, Nobuhisa Ando, Yoshimasa Shiraishi, Keiichi Ota, Kentaro Tanaka, Yoichi Nakanishi, Isamu Okamoto
Topics & Concepts
CalreticulinDocetaxelCytotoxic T cellMedicineCancer researchOsimertinibLung cancerImmunogenic cell deathEpidermal growth factor receptorTyrosine kinaseChemotherapyPharmacologyCancer cellCancerInternal medicineBiologyErlotinibReceptorCell biologyIn vitroBiochemistryEndoplasmic reticulumLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis